CMPX – compass therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $10.00 price target on the stock.
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $10.00 price target on the stock.
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at JMP Securities.
Form 4 Compass Therapeutics, For: Nov 16 Filed by: Schuetz Thomas J.
Form SCHEDULE 13G Compass Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Form SCHEDULE 13G/A Compass Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC
Form 10-Q Compass Therapeutics, For: Sep 30
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.